Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2013

May 14, 2013

30339_dirs_2013-05-14_ad1dfcf2-362f-41c4-bf89-07f83916ca91.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2012-11-06

Reporting Person: Lennartz Heino (President Europe)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-11-06 Common Stock F 17496.0000 $54.1200 Disposed 4427.0000 Direct

Footnotes

F1: Amendment filed to correct the number of shares due to the tax liability. Orginal reported amount of 17,466 has now been corrected to 17,496.